Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI assessment of nasal decongestant effect of Vicks Sinex Micromist vs sham
2011-002443-10Phase 4Completed
- Sponsor
- Procter & Gamble
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Mucinex Full Force Nasal Spray in nasal congestion, upper respiratory infection (URI) and allergic rhinitis (AR) (2 arms), sponsored by Procter & Gamble. Primary endpoint: Utility of MRI in demonstrating nasal decongestant efficacy at 8 and 12 hours. Started Jun 2011; status: completed.
02
Drugs
Mucinex Full Force Nasal Spray
03
Conditions
nasal congestionupper respiratory infection (URI)allergic rhinitis (AR)
Beyond the preview
Go deeper on 2011-002443-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002443-10.